Concord Wealth Partners 9 Meters Biopharma, Inc. Transaction History

Concord Wealth Partners

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2021 Nov 09, 2021	SELL	$1.03 - $1.41 $1,030 - $1,410	-1,000 Closed	0 $0
Q2 2021 Jul 29, 2021	SELL	$1.04 - $1.5 $1,040 - $1,500	-1,000 Reduced 50.0%	1,000 $1,000
Q1 2021 May 13, 2021	BUY	$0.84 - $2.16 $1,680 - $4,320	2,000 New	2,000 $2,000

67.9K

Ticker NMTR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 12,955,400
Market Cap $259K
Description
9 Meters Biopharma, Inc., a clinical-stage biopharmaceutical company, focuses on treatments for people with rare digestive diseases, gastrointestinal conditions with unmet needs, and debilitating disorders. The company is developing Larazotide, an 8-amino acid peptide, which is in Phase 3 clinical trial for the treatment of celiac disease, as we...

Get notified when there are updates to the investment portfolio of Concord Wealth Partners, based on Form 13F filings with the SEC.

Stay updated on Concord Wealth Partners with notifications on news.